Specialized GPCR Heteromer Inhibitors for Niche Applications
Legal Citation
Summary of the Inventive Concept
This inventive concept adapts GPCR heteromer inhibitors for specific, high-need markets, such as high-security facilities, disaster relief, extreme weather conditions, remote areas, and high-altitude areas.
Background and Problem Solved
The original patent disclosed GPCR heteromer inhibitors for cancer treatment, but these inhibitors may not be suitable for unique operational environments. This inventive concept addresses the need for specialized inhibitors that can effectively treat cancer in these niche markets.
Detailed Description of the Inventive Concept
The new inventive concept involves adapting CXCR4-HRH1 heteromer inhibitors for specific use cases, such as high-security facilities, disaster relief, extreme weather conditions, remote areas, and high-altitude areas. For example, the inhibitor may be formulated for administration in extreme weather conditions or packaged with secure data storage units for high-security facilities. The inventive concept also encompasses systems and kits that integrate these inhibitors with specialized equipment, such as satellite communication devices and weather-resistant containers, to ensure effective treatment in these unique environments.
Novelty and Inventive Step
The new claims introduce novel, specialized variations of GPCR heteromer inhibitors that are tailored to specific, high-need markets. The inventive step lies in the recognition of these niche markets and the adaptation of the original inhibitors to meet their unique requirements.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include adapting the inhibitors for use in other niche markets, such as space exploration or military operations. Variations could include different formulations, dosing regimens, or packaging configurations tailored to specific use cases.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the pharmaceutical and biotechnology industries, particularly in the areas of cancer treatment and niche market applications. Target industries include healthcare providers, pharmaceutical companies, and government agencies involved in disaster relief and high-security operations.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K38/195 |
| A | A61 | A61K31/138 |
| A | A61 | A61K31/395 |
| A | A61 | A61K31/403 |
| A | A61 | A61K31/451 |
| A | A61 | A61K31/4545 |
| A | A61 | A61K31/47 |
| A | A61 | A61K31/495 |
| A | A61 | A61K31/5415 |
| A | A61 | A61K38/12 |
| A | A61 | A61K39/3955 |
| A | A61 | A61P35/00 |
| C | C07 | C07K16/286 |
| C | C07 | C07K16/2866 |
| A | A61 | A61K2039/505 |
| A | A61 | A61K2039/507 |
| C | C07 | C07K2317/21 |
| C | C07 | C07K2317/76 |
Original Patent Information
| Patent Number | US 11,857,600 |
|---|---|
| Title | GPCR heteromer inhibitors and uses thereof |
| Assignee(s) | GPCR THERAPEUTICS, INC. |